




"Point in Time" Regulation Content

Health Professions Act

Pharmacists Regulation
B.C. Reg. 417/2008






NOTE:

Links below go to regulation content as it was prior to the
changes made on the effective date. (PIT covers changes made
from September 19, 2009 to "current to" date of the
regulation.)




SECTION
EFFECTIVE DATE


Section 1

October 9, 2009





July 26, 2016





June 1, 2023



Section 2

January 1, 2011



Section 4

October 9, 2009





October 30, 2009





December 3, 2015





June 1, 2023



Section 4.1

October 9, 2009





July 26, 2016





June 1, 2023



Schedule A

June 1, 2023









Section 1 definition of "practice of pharmacy", paragraph (a.1) was
added by BC Reg 234/2009, effective October 9, 2009.



Section 1 definition of "substance" was added by BC Reg 234/2009,
effective October 9, 2009.





Section 1 definition of "medical assistance in dying" was added by
BC Reg 201/2016, effective July 26, 2016.





Section 1 definition of "practice of pharmacy", paragraph (a.1)
BEFORE amended by BC Reg 111/2023, effective June 1, 2023.




(a.1)

promoting health and preventing diseases, disorders and conditions
through drug therapy,



Section 1 definition of "substance" BEFORE amended by BC Reg
111/2023, effective June 1, 2023.


"substance"
means a drug that is not specified in Schedule I, IA, II or IV of
the Drug Schedules Regulation.





Section 2 (e) was added by BC Reg 211/2010, effective January 1,
2011.





Section 4 (1) (c.1) was added by BC Reg 234/2009, effective October
9, 2009.





Section 4 (1) (c.1) BEFORE amended by BC Reg 256/2009, effective
October 30, 2009.


(c.1) in respect of a drug specified in Schedule I, IA or II of
the Drug Schedules Regulation or a substance,


(i)  administer the drug or substance by intramuscular or
subcutaneous injection, or


(ii)  administer the drug or substance by any method for the
purpose of treating anaphylaxis arising from administering a drug or
substance by intradermal, intramuscular or subcutaneous injection,
as described in subparagraph (i);





Section 4 (1) (c.1) (i) and (ii) BEFORE amended by BC Reg 225/2015,
effective December 3, 2015.




(i)

administer the drug or substance by intradermal, intramuscular or
subcutaneous injection, or




(ii)

administer the drug or substance by any method for the purpose of
treating anaphylaxis arising from administering a drug or substance
by intradermal, intramuscular or subcutaneous injection, as
described in subparagraph (i);





Section 4 (1) (a), (b) and (c) BEFORE amended by BC Reg 111/2023,
effective June 1, 2023.




(a)

prescribe a drug specified in Schedule IV of the Drug Schedules
Regulation to be used for emergency contraception;




(b)

compound a drug specified in Schedule I, IA, II or IV of
the Drug Schedules Regulation;




(c)

dispense a drug specified in Schedule I, IA, II or IV of
the Drug Schedules Regulation;



Section 4 (a.1) and (a.2) were added by BC Reg 111/2023, effective
June 1, 2023.





Section 4.1 was enacted by BC Reg 234/2009, effective October 9,
2009.





Section 4.1 was renumbered as section 4.1 (1) and (2) was added by
BC Reg 201/2016, effective July 26, 2016.





Section 4.1 (1) was renumbered as section 4.1 (1.1) and (1) was
added by BC Reg 111/2023, effective June 1, 2023.





Schedule A was enacted by BC Reg 111/2023, effective June 1, 2023.





